Rocket Pharmaceuticals, Inc.

Cranbury, United States

Rocket Pharmaceuticals, Inc. is a biotechnology company focused on developing innovative gene therapies for rare diseases, particularly those caused by genetic mutations. The company aims to provide transformative treatments for patients with rare and life-threatening diseases through a robust pipeline of product candidates.

CCI Score

-15.14

0.02% April 18

Latest Event

Rocket Pharmaceuticals 2022 Lobbying Expenditure

Rocket Pharmaceuticals spent $20,000 on lobbying efforts in 2022, as reported by OpenSecrets. This expenditure reflects the company's engagement in political lobbying, raising concerns about its influence on regulatory policies and political outcomes.

Take Action

So what can you do? It's time to make tough choices. Where will you cast your vote?

Shop Alternatives SEE ALL: Argenx

Verona Pharma

BMS
Use Your Voice OTHER TOOLS
Investigate
Share the Score SUPPORT CCI

ENABLER

Rocket Pharmaceuticals, Inc. is currently rated as an Enabler.

-10 to -19 CCI Score

Companies in this segment facilitate authoritarian practices while claiming neutrality. They provide resources or support that indirectly bolster oppressive regimes, thereby undermining democratic accountability without overtly endorsing the regime.

Latest Events

DEC

31

2022

Rocket Pharmaceuticals 2022 Lobbying Expenditure
-15.89

Rocket Pharmaceuticals spent $20,000 on lobbying efforts in 2022, as reported by OpenSecrets. This expenditure reflects the company's engagement in political lobbying, raising concerns about its influence on regulatory policies and political outcomes.
-20

Political Contributions and Lobbying Efforts

April 15

The spending of $20,000 on lobbying, as documented by OpenSecrets, indicates Rocket Pharmaceuticals' active involvement in political lobbying. Such activities can be used to influence policy in favor of corporate interests, potentially undermining democratic accountability and progressive regulatory measures. From an anti-fascist perspective, corporate political engagement that might contribute to regulatory capture and authoritarian influence is viewed negatively.

Rocket Pharmaceuticals Lobbying Profile
DEC

31

2021

Rocket Pharmaceuticals Spends $30K on Lobbying
-14.38

OpenSecrets data indicates that Rocket Pharmaceuticals spent $30,000 on federal lobbying in 2021, with data downloaded on February 19, 2025, highlighting the company's political engagement.
-20

Political Contributions and Lobbying Efforts

April 15

The reported $30,000 spent on lobbying in 2021 demonstrates Rocket Pharmaceuticals' active engagement in political influence. Such spending, while modest in absolute terms, reflects corporate involvement in political activities that can shape policy outcomes in favor of business interests, raising concerns about the potential for undermining democratic accountability and fostering authoritarian influences.

Rocket Pharmaceuticals Lobbyists